XPA Antibody

Code CSB-PA238469
Size US$297
Order now
Image
  • Immunohistochemistry analysis of paraffin-embedded human breast carcinoma tissue using XPA antibody.
  • Western blot analysis of extracts from COLO205 cells, using XPA antibody.
  • Western blot analysis of extracts from COS7 cells (Lane 2), using XPA antiobdy. The lane on the left is treated with systhesized peptide.
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Full Product Name
Rabbit anti-Homo sapiens (Human) XPA Polyclonal antibody
Uniprot No.
Target Names
XPA
Alternative Names
DNA repair protein complementing XP A cells antibody; DNA repair protein complementing XP-A cells antibody; DNA repair protein complementing XPA cells antibody; Excision repair controlling antibody; Xeroderma pigmentosum 1 antibody; Xeroderma pigmentosum complementation group A antibody; Xeroderma pigmentosum group A complementing protein antibody; Xeroderma pigmentosum group A-complementing protein antibody; XP 1 antibody; XP1 antibody; xpa antibody; XPA_HUMAN antibody; Xpac antibody
Raised in
Rabbit
Species Reactivity
Human,Mouse
Immunogen
Synthesized peptide derived from Internal of Human XPA.
Immunogen Species
Homo sapiens (Human)
Clonality
Polyclonal
Purification Method
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration
It differs from different batches. Please contact us to confirm it.
Form
Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Tested Applications
ELISA,WB,IHC
Recommended Dilution
Application Recommended Dilution
WB 1:500-1:3000
IHC 1:50-1:100
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Involved in DNA excision repair. Initiates repair by binding to damaged sites with various affinities, depending on the photoproduct and the transcriptional state of the region. Required for UV-induced CHEK1 phosphorylation and the recruitment of CEP164 to cyclobutane pyrimidine dimmers (CPD), sites of DNA damage after UV irradiation.
Gene References into Functions
  1. It provides evidence for an H4K20me2-dependent mechanism of XPA recruitment during lesion recognition in the global-genomic branch of NER. PMID: 29233865
  2. This study suggested that the XPA gene rs1800975 Polymorphism was associated with lung cancer susceptibility. By performing multiple separate pairwise comparisons, carriers with AG genotype under the codominant genetic model (AG vs. AA) might play actually the leading role in associating with lung cancer susceptibility in overall and in Asians. PMID: 27460688
  3. We have suggested that the nuclear localization signal on XPA is masked, perhaps in a complex with a cytosolic XPA sequestration protein, and that this complex is disrupted by methanol fixation in non-stressed cells and as part of the DNA damage response following UV irradiation PMID: 29078114
  4. It can be concluded that A23G XPA polymorphism might contribute to increased lung cancer risk in North Indian population emphasizing on poor survival among females PMID: 29516319
  5. molecular analysis of the 5 other exons of the XPA gene, showed that the 2 negative siblings carried no mutation in the XPA gene. This finding suggests that c.682C>T (p.Arg228X) mutation is relatively associated with moderate phenotype in XP group A Moroccan families PMID: 29208038
  6. XPA rs1800975 polymorphism may decrease the risk of breast cancer in both non-Asians and population-based patients PMID: 29953005
  7. Our results indicate that increased XP-1 levels were associated with PCOS after adjustment for potential confounders, which has been shown to be effective in the function of the insulin signaling pathway. PMID: 28831586
  8. data obtained allow us to suggest that XPA can be involved in the post-incision NER stages via its interaction with RPA PMID: 29320546
  9. Data suggest that the multi-protein interactions involved in the nucleotide excision repair (NER) process and potential cytotoxic mechanism associated with Ni(2+) binding in xeroderma pigmentosum complementation group A protein (XPA) may facilitate rational anti-cancer drug design based on the NER mechanism. PMID: 27307058
  10. XPA status does not globally influence human gene transcription. However, XPA significantly influences expression of a small subset of genes important for mitochondrial functions and steroid hormone metabolism. PMID: 28704716
  11. These results suggest that for XPA mutants exhibiting altered DNA-binding properties, a correlation exists between the extent of reduction in DNA-binding affinity and the severity of symptoms in XP patients. PMID: 28860187
  12. These results propose a mechanism for progerin-induced genome instability and accelerated replicative senescence in Hutchinson-Gilford progeria syndrome. PMID: 28515154
  13. These results illustrate that EZH2 may promote carcinogenesis and cancer development of nasopharyngeal carcinoma by transcriptional repression of XPA gene and inactivation of nucleotide excision repair pathway. PMID: 27253463
  14. SNP rs10817938 in promoter region associated with poor prognosis of oral squamous cell carcinoma in Chinese Han population PMID: 27622501
  15. We showed that loss of HERC2 function leads to the accumulation of XPA and BRCA1 in the patient's fibroblasts and generates decreased sensitivity to apoptosis and increased level of DNA repair PMID: 27759030
  16. Accumulating evidence suggests that XPA and the helicase activity of transcription factor IIH (TFIIH) cooperate to verify abnormalities in damaged DNA chemistry. (Review) PMID: 27264556
  17. XPA is a key scaffold protein for human nucleotide excision repair. (Review) PMID: 27247238
  18. XPA reduction increased cell viability of a bladder cancer cell line RT4, while XPA re-expression decreased the cell viability of RT4 cells. Study suggests that downregulated XPA may promote carcinogenesis of bladder cancer via impairment of DNA repair. PMID: 28222669
  19. The risk of esophageal squamous cell carcinoma associated with XPA rs-1800975 was determined. A high ESCC risk was found in subjects who carried the homozygous minor allele of XPA, especially in smokers, those in adobe houses, drinkers of salt tea, or those with a family history of cancer. Variant genotypes of both XPA and XPC in combination showed an increased risk towards ESCC. PMID: 26831662
  20. The role of conformational selection in the molecular recognition of the wild type and mutants XPA67-80 peptides by ERCC1 has been described. PMID: 25973722
  21. We discovered four new XP-A patients and a novel XPA mutation resulting in two diverse patient alleles. PMID: 25393472
  22. a specific XPA genotype is associated with mild phenotype in Xeroderma Pigmentosum in United Kingdom immigrants from India, Pakistan, and Afghanistan PMID: 26743599
  23. Findings suggest that xeroderma pigmentosum complementation group-A (XPA) levels may be a potential predictor of prognosis in locally advanced nasopharyngeal carcinoma (NPC) patients treated with platinum-based chemoradiotherapy. PMID: 26156020
  24. Upon UVC radiation, Nlp interacts with XPA and ERCC1, and enhances their association PMID: 26805762
  25. Data suggest an association of high mobility group box 1 (HMGB1) with xeroderma pigmentosum complementation group A (XPA) protein facilitates the formation of a favorable architectural environment for DNA interstrand crosslinks (ICLs) repair processing. PMID: 26578599
  26. The lack of XPA significantly enhanced the mutant proportion of tandem 8-oxoG in the transcribed strand (12%) compared with that in TSCER122 cells (7.4%) but not in the non-transcribed strand. PMID: 26559182
  27. Xeroderma pigmentosum syndrome is rarely associated with inherited disease-causing XPA mutations in the Brazilian population. PMID: 25913378
  28. This study identified 13 novel mutations and extended the mutation spectrum of XP in the Chinese Han population PMID: 25256075
  29. A tripartite lesion verification mechanism involving XPC, TFIIH, and XPA is necessary for efficient nucleotide excision repair. PMID: 26384665
  30. Homozygous mutations in the XPA gene were seen in xeroderma pigmentosum patients with moderate to severe mental retardation (6/10 families) but not in those without neurological features. PMID: 25566891
  31. Data indicate that residues lysine K221, K222, K224 and K236 in the C-terminal domain of XPA (xeroderma pigmentosum group A) protein are involved in DNA binding. PMID: 25385088
  32. structure of DNA-binding domain of human XPA PMID: 25056193
  33. by detecting the SNPs in blood cells, XPA A23G polymorphic variants might be a promising biomarker in predicting a favor prognosis of NSCLC patients and be helpful towards designing individualized treatments. PMID: 23617284
  34. As RASSF1A modulates both apoptotic DDR and XPA-mediated DNA repair, it may coordinate the balance between repair and death after DNA damage PMID: 25368379
  35. XPA single nucleotide polymorphism and gene frequency in Russians, Tatars and Bashkirs. PMID: 25474887
  36. The XRCC1 rs25487 polymorphism and the XPA rs1800975 polymorphism might exert both independent and interactive effects on the development of breast cancer among northern Chinese women. PMID: 24642895
  37. XPA and PARP1 regulate each other in a reciprocal and poly(ADP-ribose)-dependent manner. PMID: 24953096
  38. Our study suggested that XPA rs1800975 polymorphism might associate with lung cancer risk in overall and in East Asians. PMID: 24696258
  39. Loss of Ser435 within ATR prevents PKA-mediated ATR phosphorylation, disrupts ATR-XPA binding, delays recruitment of XPA to UV-damaged DNA, and elevates UV-induced mutagenesis. PMID: 24950377
  40. Mutation analysis of the candidate XP gene revealed a novel deletion mutation (c.654del A) in exon 5 of XPA gene, which causes frameshift, pre-maturely terminating protein and resulting into a truncated product of 222 amino acid residues instead of 273. PMID: 24063568
  41. Homology modelling corroborates the very close similarity between hydra and human XPA. PMID: 24083246
  42. ATR-mediated phosphorylation induces XPA stabilization by antagonizing HERC2-catalyzed XPA ubiquitination. PMID: 23178497
  43. Transcriptionally active p73 induces translocation of xeroderma pigmentosum group A during apoptosis caused by melphalan. PMID: 24249729
  44. upon DNA damage transport adaptor importin-alpha4 imports XPA into the nucleus in an ATR-dependent manner. PMID: 23861882
  45. report the identification of one novel XPA gene mutation and two known mutations in four unrelated Egyptian families with Xermoderma pigmentosum PMID: 24135642
  46. structure and dynamics of the XPA binding motif in ERCC1 PMID: 23746523
  47. XPA SNPs do not appear to play a major role in lymphoma susceptibility in a Spanish population. PMID: 23818366
  48. XPA genetic polymorphism is associated with esophageal squamous cell carcinoma. PMID: 22941172
  49. We determined the age of the most recent common ancestor of the XPA founder mutation to be 120 generations in Japanese. PMID: 23194742
  50. analysis of novel inhibitors that block XPA-ERCC1 binding PMID: 23272099

Show More

Hide All

Involvement in disease
Xeroderma pigmentosum complementation group A (XP-A)
Subcellular Location
Nucleus.
Protein Families
XPA family
Tissue Specificity
Expressed in various cell lines and in skin fibroblasts.
Database Links

HGNC: 12814

OMIM: 278700

KEGG: hsa:7507

STRING: 9606.ENSP00000364270

UniGene: Hs.654364

CUSABIO guaranteed quality
icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*